Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Somira Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Somira Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 301 · Grade C

Somira Health

Visit Somira Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Somira Health a bad call — it's best for readers who want to compare compounded formulations and will verify their pharmacy, full payment and renewal settings first. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
46
Supply Reliability
95
75
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
77
Track Record
88
68
CoreAge RxBrief Score 94 · 64Somira Health

Price, coverage & the tracker

CoreAge RxSomira Health
Brief Score94/100 (A)64/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Current selected-plan quote unconfirmed

Compounded injection with B12 or glycine options described; earlier $190/month listing is historical.

Access and consultation fees can become nonrefundable before pharmacy transmission. Most plans can auto-renew; pausing alone may not stop charges.

Full price details

Compounded semaglutide injections offered with B12 or glycine options; complete current selected-plan quote unknown; earlier listing from $190/mo is historical

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Current selected-plan quote unconfirmed

Compounded injection with B12 or glycine options described; earlier $285/month listing is historical.

Access and consultation fees can become nonrefundable before pharmacy transmission. Most plans can auto-renew; pausing alone may not stop charges.

Full price details

Compounded tirzepatide injections offered with B12 or glycine options; complete current selected-plan quote unknown; earlier listing from $285/mo is historical

CoverageUS only; restrictions by state, confirmed at intakeProvider network advertises 50 states, D.C. and Puerto Rico; actual treatment access also requires compliant pharmacy fulfillment
Brand-name accessNot confirmedBranded drug labeling is linked for safety information; it does not establish a current branded-medication program.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Somira Health: Complete selected-plan price unconfirmed. Plans may auto-renew; access and consultation fees have earlier refund cutoffs than pharmacy transmission. Confirm each charge before paying.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.